EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiviral Activity of Medicinal Plant Extracts Vitex negundo and Macaranga tanarius Against SARS-CoV-2

Muhareva Raekiansyah, Mya Myat Ngwe Tun iD, Alexandra Ang iD, Alexandra Lee, Stephani Joy Macalino iD, Junie Billones iD, Yuki Takamatsu iD, Takeshi Urano, Lyre Anni E Murao iD, Noel Quiming, Kouichi Morita iD, Maria Constancia Carrillo iD

Pathogens · 19.08.2025 · 14 (8) · 820

DOI: 10.3390/pathogens14080820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 19.08.2025. Verfasst von Muhareva Raekiansyah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan. Hauptthemen laut MEDLINE: Vitex, Plant Extracts, Antiviral Agents, SARS-CoV-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency of Medical Research and Development, Japanese Society of Promotion and Science (JSPS), SDGs Research Project of Shimane University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural products possess a wide range of biological and biochemical potentials, with plant-derived compounds being significant sources for discovering new drugs. In this study, extracts of Vitex negundo and Macaranga tanarius prepared with different solvents were tested for their antiviral activity against the original SARS-CoV-2 Wuhan strain and its variants using plaque assay, quantitative real time RT-PCR, and immunofluorescence assay (IFA). Our results showed that at their maximum non-toxic concentrations, Vitex-Dichloromethane (DCM) and Macaranga extracts significantly inhibited SARS-CoV-2 Wuhan strain growth in Vero E6 cells, showing a 5-log reduction in plaque assay and confirmed by IFA. Meanwhile, Vitex-Hexane showed moderate activity with a 2-log decrease. The inhibition was shown in a dose-dependent manner. The antiviral efficacy of these extracts was further demonstrated against various SARS-CoV-2 variants including Alpha, Beta, Delta, and Omicron. Both Vitex-DCM and Macaranga showed strong virucidal activity. In addition, Vitex-DCM and Macaranga inhibited the transcriptional activity of purified SARS-CoV-2 RdRp, indicating that RdRp inhibition may contribute to viral suppression as shown at the post-infection stage. Furthermore, combining Vitex-DCM or Macaranga with remdesivir showed a synergistic effect against SARS-CoV-2. These results suggest that Vitex negundo and Macaranga tanarius extracts are promising candidates for anti-SARS-CoV-2 treatments. Their synergy with remdesivir also underscores the potential of drug combinations in fighting SARS-CoV-2 and preventing the emergence of mutant variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitexPlant ExtractsAntiviral AgentsSARS-CoV-2COVID-19 Drug TreatmentPlants, MedicinalChlorocebus aethiopsAnimalsVero CellsHumansCOVID-19

Stichwörter der Autor:innen

Macaranga tanariusSARS-CoV-2Vitex negundoantiviral

Substanzen

Plant ExtractsAntiviral Agents

Autor:innen und Institutionen

  • Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
  • Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
  • Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo 690-8504, Japan.
  • DEJIMA Infectious Diseases Research Alliance, Nagasaki University, Nagasaki 852-8523, Japan.
  • Department of Physical Sciences and Mathematics, College of Arts and Sciences, University of the Philippines Manila, Manila 1000, Philippines.
  • Department of Chemistry, College of Science, De La Salle University, Manila 0922, Philippines.

ORCID-Profile: Mya Myat Ngwe Tun, Alexandra Ang, Stephani Joy Macalino, Junie Billones, Yuki Takamatsu, Lyre Anni E Murao, Kouichi Morita, Maria Constancia Carrillo

Förderung

  • Japan Agency of Medical Research and Development
  • Japanese Society of Promotion and Science (JSPS)
  • SDGs Research Project of Shimane University
  • Philippine Council for Health Research and Development (PCHRD)

Zitieren

APA

Raekiansyah, M., Ngwe Tun, M. M., Ang, A., Lee, A., Macalino, S. J., Billones, J., Takamatsu, Y., Urano, T., Murao, L. A. E., Quiming, N., Morita, K., & Carrillo, M. C. (2025). Antiviral Activity of Medicinal Plant Extracts Vitex negundo and Macaranga tanarius Against SARS-CoV-2. Pathogens, 14(8), 820. https://doi.org/10.3390/pathogens14080820

Vancouver

Raekiansyah M, Ngwe Tun MM, Ang A, Lee A, Macalino SJ, Billones J, et al. Antiviral Activity of Medicinal Plant Extracts Vitex negundo and Macaranga tanarius Against SARS-CoV-2. Pathogens. 2025;14(8):820. doi:10.3390/pathogens14080820

BibTeX
@article{Raekiansyah2025,
  author = {Raekiansyah, Muhareva and Ngwe Tun, Mya Myat and Ang, Alexandra and Lee, Alexandra and Macalino, Stephani Joy and Billones, Junie and Takamatsu, Yuki and Urano, Takeshi and Murao, Lyre Anni E and Quiming, Noel and Morita, Kouichi and Carrillo, Maria Constancia},
  title = {Antiviral Activity of Medicinal Plant Extracts Vitex negundo and Macaranga tanarius Against SARS-CoV-2},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {8},
  pages = {820},
  doi = {10.3390/pathogens14080820}
}
Kostenlos starten →